Synapse Open Synapse
Biology

Sanofi, Regeneron broaden alliance to find their next Dupixent

BioPharma Dive · · 2 min read

The deal carries a $1 billion upfront payment and tasks the two companies to develop long-acting antibody drugs that go after the same targets as their blockbuster anti-inflammation agent.

Latest from BioPharma Dive